{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T03:46:13Z","timestamp":1768794373970,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s40265-024-02001-y","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T16:02:06Z","timestamp":1707321726000},"page":"203-208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Methadone for Cancer Pain Management in Children: A Review of Literature"],"prefix":"10.1007","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9859-6487","authenticated-orcid":false,"given":"Sebastiano","family":"Mercadante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,7]]},"reference":[{"key":"2001_CR1","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(17)30186-9","volume":"18","author":"E Steliarova-Foucher","year":"2017","unstructured":"Steliarova-Foucher E, Colombet M, Ries LAG, et al. International incidence of childhood cancer, 2001\u201310: a population-based registry study. Lancet Oncol. 2017;18:719\u201371.","journal-title":"Lancet Oncol"},{"key":"2001_CR2","unstructured":"World Health Organization (2021) CureAll framework: WHO global initiative for childhood cancer: increasing access, advancing quality, saving lives. World Health Organization.\u00a0https:\/\/apps.who.int\/iris\/handle\/10665\/347370."},{"issue":"6432","key":"2001_CR3","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1126\/science.aaw4892","volume":"363","author":"CG Lam","year":"2019","unstructured":"Lam CG, Howard SC, Bouffet E, Pritchard-Jones K. Science and health for all children with cancer. Science. 2019;363(6432):1182\u20136.","journal-title":"Science"},{"key":"2001_CR4","unstructured":"World Health Organization (2020) Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2019 global survey. World Health Organization.\u00a0https:\/\/apps.who.int\/iris\/handle\/10665\/331452"},{"key":"2001_CR5","unstructured":"WHO 2012 World Health Organization. WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses. apps.who.int\/iris\/bitstream\/10665\/44540\/1\/9789241548120_Guidelines.pdf"},{"issue":"7","key":"2001_CR6","first-page":"CD012564","volume":"7","author":"PJ Wiffen","year":"2017","unstructured":"Wiffen PJ, Cooper TE, Anderson AK, et al. Opioids for cancer-related pain in children and adolescents. Cochrane Database Syst Rev. 2017;7(7):CD012564.","journal-title":"Cochrane Database Syst Rev"},{"key":"2001_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40265-019-01234-6","volume":"80","author":"KP Edmonds","year":"2020","unstructured":"Edmonds KP, Saunders IM, Willeford A, Ajaji TA, Atayee RS. Emerging challenges to the safe and effective use of methadone for cancer-related pain in paediatric and adult patient populations. Drugs. 2020;80:115\u201330.","journal-title":"Drugs"},{"key":"2001_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s40272-018-0304-2","volume":"20","author":"C Habashy","year":"2018","unstructured":"Habashy C, Springer E, Hall EA, Anghelescu DL. Methadone for pain management in children with cancer. Paediatr Drugs. 2018;20:409\u201316.","journal-title":"Paediatr Drugs"},{"key":"2001_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0304-3940(95)11364-3","volume":"187","author":"B Ebert","year":"1995","unstructured":"Ebert B, Andersen S, Krogsgaard-Larsen P. Ketobemidone, methadone and pethidine are non-competitive N-methyl-d-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci Lett. 1995;187:165\u20138.","journal-title":"Neurosci Lett"},{"key":"2001_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0304-3940(97)13391-2","volume":"223","author":"AL Gorman","year":"1997","unstructured":"Gorman AL, Elliott KJ, Inturrisi CE. The d- and l-isomers of methadone bind to the non-competitive site on the N-methyld- aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci Lett. 1997;223:5\u20138.","journal-title":"Neurosci Lett"},{"issue":"Suppl 1","key":"2001_CR11","doi-asserted-by":"publisher","first-page":"S191","DOI":"10.33549\/physiolres.932678","volume":"63","author":"V Vyklicky","year":"2014","unstructured":"Vyklicky V, Korinek M, Smejkalova T, Balik A, Krausova B, Kaniakova M, et al. Structure, function, and pharmacology of NMDA receptor channels. Physiol Res. 2014;63(Suppl 1):S191-203.","journal-title":"Physiol Res"},{"key":"2001_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1126\/science.1824728","volume":"251","author":"KA Trujillo","year":"1991","unstructured":"Trujillo KA, Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science. 1991;251:85\u20137.","journal-title":"Science"},{"issue":"1 Suppl","key":"2001_CR13","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/S0885-3924(99)00121-9","volume":"19","author":"DD Price","year":"2000","unstructured":"Price DD, Mayer DJ, Mao J, Caruso FS. NMDA-receptor antagonists and opioid receptor interactions as related to analgesia and tolerance. J Pain Symptom Manag. 2000;19(1 Suppl):S7-11.","journal-title":"J Pain Symptom Manag"},{"key":"2001_CR14","first-page":"1048","volume":"289","author":"AM Davis","year":"1999","unstructured":"Davis AM, Inturrisi CE. d-Methadone blocks morphine tolerance and N-methyl-d-aspartate-induced hyperalgesia. J Pharmacol Exp Ther. 1999;289:1048\u201353.","journal-title":"J Pharmacol Exp Ther"},{"key":"2001_CR15","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1080\/03602532.2016.1192642","volume":"48","author":"RJ Dinis-Oliveira","year":"2016","unstructured":"Dinis-Oliveira RJ. Metabolomics of methadone: clinical and forensic toxicological implications and variability of dose response. Drug Metab Rev. 2016;48:568\u201376.","journal-title":"Drug Metab Rev"},{"key":"2001_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.5055\/jom.2013.0167","volume":"9","author":"MJH Beuken-van Everdingen","year":"2013","unstructured":"Beuken-van Everdingen MJH, Geurts JW, Patijn J. Prolonged QT interval by methadone: relevance for daily practice. J Opioid Manage. 2013;9:263\u20137.","journal-title":"J Opioid Manage."},{"key":"2001_CR17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jpainsymman.2018.11.009","volume":"57","author":"K Madden","year":"2019","unstructured":"Madden K, Liu D. Bruera E Attitudes, beliefs, and practices of pediatric palliative care physicians regarding the use of methadone in children with advanced cancer. J Pain Symptom Manage. 2019;57:260\u20135.","journal-title":"J Pain Symptom Manage"},{"key":"2001_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/MPH.0b013e318279e492","volume":"35","author":"M Roth","year":"2013","unstructured":"Roth M, Davies D, Friebert S, Wang D, Kim M, Zelcer S. Attitudes and practices of pediatric oncologists regarding methadone use in the treatment of cancer-related pain: results of a North American Survey. J Pediatr Hematol Oncol. 2013;35:103\u20137.","journal-title":"J Pediatr Hematol Oncol"},{"key":"2001_CR19","unstructured":"http:\/\/www.prisma-statement.org\/PRISMAStatement\/Checklist.aspx"},{"key":"2001_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.5055\/jom.2011.0076","volume":"7","author":"DL Anghelescu","year":"2011","unstructured":"Anghelescu DL, Faughnan LG, Hankins GM, Ward DA, Oakes LL. Methadone use in children and young adults at a cancer center: a retrospective study. J Opioid Manag. 2011;7:353\u201361.","journal-title":"J Opioid Manag"},{"key":"2001_CR21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/pbc.21584","volume":"51","author":"D Davies","year":"2008","unstructured":"Davies D, DeVlaming D, Haines C. Methadone analgesia for children with advanced cancer. Pediatr Blood Cancer. 2008;51:393\u20137.","journal-title":"Pediatr Blood Cancer"},{"key":"2001_CR22","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1177\/1049909120963641","volume":"38","author":"EA Hall","year":"2021","unstructured":"Hall EA, Sauer HE, Habashy C, Anghelescu DL. Methadone for cancer pain in pediatric end-of-life care. Am J Hosp Palliat Med. 2021;38:914\u20139.","journal-title":"Am J Hosp Palliat Med"},{"key":"2001_CR23","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1089\/jpm.2017.0712","volume":"21","author":"K Madden","year":"2018","unstructured":"Madden K, Milla S, Dibaj S, Williams JL, Liu D, Bruera E. Methadone as the initial long-acting opioid in children with advanced cancer. J Palliat Med. 2018;21:1317\u201321.","journal-title":"J Palliat Med"},{"key":"2001_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.25259\/IJPC_383_20","volume":"27","author":"G Palat","year":"2021","unstructured":"Palat G, Algotsson C, Rayala S, Haridass V, Nethagani J, Rapelli V, Medhin MG, Brun E, Segerlantz M. The use of methadone in pediatric cancer pain\u2014a retrospective study from a governmental cancer center in India. Indian J Palliat Care. 2021;27:133\u20138.","journal-title":"Indian J Palliat Care"},{"key":"2001_CR25","first-page":"86","volume":"5","author":"C Mott","year":"2018","unstructured":"Mott C, Sarpal A, Moss K, Herbetr A. Methadone for analgesia in children with life-limiting illness: experience from a tertiary children\u2019s health service. Children (Basel). 2018;5:86.","journal-title":"Children (Basel)."},{"key":"2001_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.5055\/jom.2016.0325","volume":"12","author":"DL Anghelescu","year":"2016","unstructured":"Anghelescu DL, Patel RM, Mahoney DP, Trujillo L, Faughnan LG, Steen BD, Baker JN. Methadone prolongs cardiac conduction in young patients with cancer-related pain. J Opioid Manag. 2016;12:131\u20138.","journal-title":"J Opioid Manag"},{"key":"2001_CR27","doi-asserted-by":"crossref","unstructured":"Madden K, Park M, Liu D, Bruera E. The frequency of QTc prolongation among pediatric and young adult patients receiving methadone for cancer pain. Pediatr Blood Cancer. 2017;64(11).","DOI":"10.1002\/pbc.26614"},{"key":"2001_CR28","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.jpainsymman.2019.05.021","volume":"58","author":"K Madden","year":"2019","unstructured":"Madden K, Jo E, Williams JL, Liu D, Bruera E. Corrected QT interval prolongation in pediatric and young adult patients on methadone for cancer-related pain. J Pain Symptom Manage. 2019;58:678\u201384.","journal-title":"J Pain Symptom Manage"},{"key":"2001_CR29","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1097\/MPH.0000000000001444","volume":"42","author":"JA Piccinini","year":"2020","unstructured":"Piccinini JA, Killinger JS, Hammad HT, Gerber LM, Dayton JD. QT interval prolongation in the pediatric oncologic population on methadone. J Pediatr Hematol Oncol. 2020;42:e121\u20134.","journal-title":"J Pediatr Hematol Oncol"},{"key":"2001_CR30","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ejpain.2005.09.002","volume":"10","author":"B Zernikow","year":"2006","unstructured":"Zernikow B, Smale H, Michel E, et al. Paediatric cancer pain management using the WHO analgesic ladder\u2013results of a prospective analysis from 2265 treatment days during a quality improvement study. Eur J Pain. 2006;10:587\u201395.","journal-title":"Eur J Pain"},{"key":"2001_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2165\/00148581-200911020-00004","volume":"11","author":"B Zernikow","year":"2009","unstructured":"Zernikow B, Michel E, Craig F, Anderson BJ. Pediatric palliative care: use of opioids for the management of pain reported. Paediatr Drugs. 2009;11:129\u201351.","journal-title":"Paediatr Drugs"},{"key":"2001_CR32","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jpainsymman.2018.12.001","volume":"57","author":"ML McPherson","year":"2019","unstructured":"McPherson ML, Walker KA, Davis M, et al. Safe and appropriate use of methadone in hospice and palliative care: expert consensus white paper. J Pain Symptom Manage. 2019;57:635\u201345.","journal-title":"J Pain Symptom Manage"},{"key":"2001_CR33","volume":"94","author":"L Di Sarno","year":"2023","unstructured":"Di Sarno L, Gatto A, Korn D. Pain management in pediatric age. An update. Acta Biomed. 2023;94: e2023174.","journal-title":"Acta Biomed"},{"key":"2001_CR34","volume-title":"Pharmacological interventions for chronic pain in pediatric patients: a review of guidelines","author":"S Banerjiee","year":"2020","unstructured":"Banerjiee S, Butcher R. Pharmacological interventions for chronic pain in pediatric patients: a review of guidelines. Ottawa: CADTH; 2020."},{"key":"2001_CR35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.critrevonc.2015.12.011","volume":"99","author":"S Mercadante","year":"2016","unstructured":"Mercadante S, Bruera E. Opioid switching in cancer pain: from the beginning to nowadays. Crit Rev Oncol Hematol. 2016;99:241\u20138.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2001_CR36","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/oncolo\/oyab081","volume":"27","author":"S Mercadante","year":"2022","unstructured":"Mercadante S, Adile C, Ferrera P, Pallotti MC, Ricci M, Bonanno G, Casuccio A. Methadone\u00a0as first-line opioid for the management of cancer pain. Oncologist. 2022;27:323\u20137.","journal-title":"Oncologist"},{"issue":"Suppl 1","key":"2001_CR37","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.4103\/IJPC.IJPC_186_17","volume":"24","author":"G Palat","year":"2018","unstructured":"Palat G, Chary S. Practical guide for using methadone in pain and palliative care practice. Indian J Palliat Care. 2018;24(Suppl 1):S21\u20139.","journal-title":"Indian J Palliat Care"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-024-02001-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-024-02001-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-024-02001-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T06:37:06Z","timestamp":1711780626000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-024-02001-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["2001"],"URL":"https:\/\/doi.org\/10.1007\/s40265-024-02001-y","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"16 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SM has no conflicts to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No funding to declare regarding the preparation of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent (participation and publication)"}},{"value":"All data generated or analyzed during this study are included in this published article.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}